FDA approves treatment for Alopecia

YUMA, Ariz. (KYMA, KECY-TV/CNN) - The FDA has approved its first treatment for Alopecia. 

Officials say "olumiant" blocks an enzyme that leads to inflammation caused by severe Alopecia Areata. This inflammation can trigger the body to attack its own hair follicles causing the hair to fall out in clumps leading to patchy baldness.

The FDA says about 300-thousand people in the U.S suffer from the autoimmune disorder.

Eli Lilly conducted two trials to receive federal approval.

In both trials, people who received the treatment maintained more of their hair.